Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-5442 (Odanacatib) in Postmenopausal Osteoporosis Previously Treated with Bisphosphonates
NCT00996801Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Nov 2009
- Primary completion
- Jun 2011
01
Overview
A Phase 2 trial of odanacatib in postmenopausal osteoporosis, sponsored by Merck & Co.. Started Nov 2009; status: completed.
02
Drugs
odanacatib
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT00996801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00996801.